Silvercrest Asset Management’s DexCom DXCM Stock Holding History

Silvercrest Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,576	Closed	-$2.85M	–	846
2023 Q3	$2.85M	Sell	30,576 -6,774	-18%	-$764K	0.02%	435
2023 Q2	$4.8M	Buy	37,350 +4,915	+15%	+$594K	0.03%	374
2023 Q1	$3.77M	Buy	32,435 +5,709	+21%	+$639K	0.03%	396
2022 Q4	$3.03M	Buy	26,726 +2,917	+12%	+$320K	0.02%	415
2022 Q3	$1.92M	Buy	23,809 +3,272	+16%	+$277K	0.02%	455
2022 Q2	$1.53M	Buy	20,537 +11,337	+123%	+$1.03M	0.01%	511
2022 Q1	$1.18M	Hold	9,200	–	–	0.01%	582
2021 Q4	$1.24M	Sell	9,200 -32	-0.3%	-$4.6K	0.01%	543
2021 Q3	$1.26M	Buy	+9,232	New	+$1.16M	0.01%	540
2020 Q1	–	Sell	-3,716	Closed	-$203K	–	730
2019 Q4	$203K	Sell	3,716 -1,868	-33%	-$88.6K	﹤0.01%	716
2019 Q3	$208K	Buy	+5,584	New	+$217K	﹤0.01%	696

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Silvercrest Asset Management's DXCM Position: Q4 2023 in Review

Silvercrest Asset Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 30,576 shares — an estimated $2.85M sold.

Silvercrest Asset Management first reported a position in DXCM in Q3 2019 and held it in 11 quarters. The position peaked at $4.8M in Q2 2023. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

Silvercrest Asset Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
Silvercrest Asset Management sold 30,576 DexCom shares in Q4 2023, an estimated $2.85M.
Silvercrest Asset Management first reported a position in DexCom in Q3 2019 and held it in 11 quarters.
Silvercrest Asset Management's DexCom position peaked at $4.8M in Q2 2023.
975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Silvercrest Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.